I liked hearing Ralph talk through things and answer some...

I liked hearing Ralph talk through things and answer some questions, but I would have liked a little more follow up on some earlier announcements. For eample:

What's happening (or happened) with Abiomed, one of the two 'anchor' clients for Sensera in MEMS? This should, by my reckoning, have brought in significant revenue for the company in Q4. Is the obtuse reference to further ISO certification related to this contract?

And a question i had for the call, arising from my recent research and reflection:

Is Sensera eligible for any Aust. Gov. R&D rebates (given its principle subsidiaries are Sensera Inc. in the US and Nanotron in Germany)?

The update and conf. call indicate very solid progress and suggest great potential, but with some curiius omissions (e.g. what of the 'military' contract, the other MEMS anchor client?)

I'd like to think we're through with the share overhang, but I'm not quite sure. GLTAH R-7